• Ever wondered if Omega Healthcare Investors is a good deal at today’s prices? If you’re trying to figure out whether now is the time to buy, you’re in the right place.
• The stock has climbed an impressive 8.8% in the past week, adding to a 13.6% gain year to date, and a remarkable 76.0% return over three years.
• Omega’s recent performance has been influenced by increased attention on real estate investment trusts, as well as several key property deals in the healthcare sector making headlines. There has been renewed optimism in the market as investors speculate about improved occupancy rates and sector resilience.
• Based on our valuation framework, Omega Healthcare Investors scores 4 out of 6 on undervaluation checks. Let’s dive into how these checks stack up against common valuation methods and why there might be an even smarter way to view its true value. More on that at the end of the article.

Approach 1: Omega Healthcare Investors Discounted Cash Flow (DCF) Analysis

The Discounted Cash Flow (DCF) model estimates what a business is worth by projecting its future cash flows, in this case Omega Healthcare Investors' adjusted funds from operations, and discounting those back to today’s value. This approach helps assess whether a stock's price reflects its underlying earnings power.

Currently, Omega Healthcare Investors reported free cash flow (FCF) stands at $778 million. Analysts forecast that by 2029, FCF may reach $1.1 billion. Projections for the next decade gradually rise and are supported by both analyst estimates and Simply Wall St extrapolations. This indicates steady growth in the company’s cash generation.

According to the DCF calculation, Omega Healthcare Investors’ estimated intrinsic value is $80.30 per share. When compared to recent market prices, this suggests the stock is trading at a 46.4% discount to its intrinsic value. In simple terms, the DCF model shows Omega Healthcare Investors could be significantly undervalued at current levels.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Omega Healthcare Investors is undervalued by 46.4%. Track this in your watchlist or portfolio, or discover 835 more undervalued stocks based on cash flows.

Approach 2: Omega Healthcare Investors Price vs Earnings (PE)

The Price-to-Earnings (PE) ratio is a widely used way to value profitable companies like Omega Healthcare Investors because it directly compares a company's market value to its current earnings. This multiple is a common benchmark for investors since it reflects what the market is willing to pay for each dollar of earnings generated by the business.

A “normal” or fair PE ratio often depends on the company’s growth prospects and risk profile. If investors expect more earnings growth or greater stability, they may be willing to pay a higher PE. On the other hand, slower growth or above-average risk typically results in a lower PE ratio.

Omega Healthcare Investors currently trades at a PE of 24.4x. This is in line with the health care REITs industry average of 24.2x and substantially below the average PE of its listed peers, which is 58.5x. However, Simply Wall St’s proprietary “Fair Ratio” for Omega Healthcare Investors is 32.9x, which factors in expected earnings growth, profit margins, risk characteristics, and the company’s size in addition to sector-specific traits.

The Fair Ratio is a more comprehensive benchmark than those based only on industry or peer averages. By considering multiple business-specific and market factors, it provides a more thorough lens for judging a stock’s valuation.

With Omega Healthcare Investors’ current PE of 24.4x compared to a Fair Ratio of 32.9x, the shares may be considered undervalued based on this metric.

Result: UNDERVALUED

PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1406 companies where insiders are betting big on explosive growth.

Upgrade Your Decision Making: Choose your Omega Healthcare Investors Narrative

Earlier we mentioned there is an even better way to understand valuation, so let's introduce you to Narratives. A Narrative gives you the story behind a company’s numbers by letting you define your own assumptions for Omega Healthcare Investors’ future revenue, earnings, and fair value. This connects your unique perspective to a clear financial forecast and resulting value estimate.

Rather than relying solely on static models or industry averages, Narratives empower you to personalize your investment thesis, test different scenarios, and see how your expectations compare to the market price. This is presented in an approachable format available on Simply Wall St's Community page, used by millions of investors.

With Narratives, when news or key financial results are released, fair values are recalculated in real time so your perspective stays relevant and data-driven. For example, some investors see Omega’s robust portfolio and legislative support justifying higher earnings and a fair value of $46.00, while others are more cautious due to tenant risks and set their fair value as low as $37.00. This flexibility allows you to compare your assumptions with others, assist in your decision on whether Omega Healthcare Investors fits your portfolio, and adapt instantly as facts change.

Do you think there's more to the story for Omega Healthcare Investors? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.